Barcelona defender Alejandro Balde may have unwittingly handed his side's Champions League opponents Atalanta some extra ...

Atalanta have outperformed their expectations in the Champions League this season and will now make one final push in their ...

Barcelona take on Atalanta in their final league phase match in the Champions League, knowing that a victory would ensure a ...

Gian Piero Gasperini is aware of the fact that Atalanta require a win away against Barcelona to guarantee themselves a spot ...

Barcelona and Atalanta meet in Catalonia on Wednesday for their final UEFA Champions League game of the league phase. Hansi ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Barcelona and Atalanta conclude the league phase of the Champions League against one another. Barcelona vs Atalanta best bets ...

Hansi Flick is keeping Wojciech Szczesny in goal for the final match of the league phase of the Champions League on Wednesday ...

Meanwhile, Atalanta are without Ivorian loanee from Leverkusen Odilon Kossounou in defence and Italian international striker ...

The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat neurological conditions like Huntington’s.

The company, co-founded by Nobel Laureate Craig Mello, aims to push molecules for Huntington’s and a form of epilepsy into Phase I trials, with additional preclinical assets targeting Parkinson’s and ...

Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.